Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advances in Biomarker Studies in Autism Spectrum Disorders
Liming Shen, Yuxi Zhao, Huajie Zhang, et al.
Advances in experimental medicine and biology (2019), pp. 207-233
Closed Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Oxidative Stress in Autism Spectrum Disorder—Current Progress of Mechanisms and Biomarkers
Xukun Liu, Lin Jing, Huajie Zhang, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 113
Autism spectrum disorder: pathogenesis, biomarker, and intervention therapy
Hongbin Zhuang, Zhiyuan Liang, Guanwei Ma, et al.
MedComm (2024) Vol. 5, Iss. 3
Open Access | Times Cited: 16
Biomarkers in autism spectrum disorders: Current progress
Liming Shen, Xukun Liu, Huajie Zhang, et al.
Clinica Chimica Acta (2019) Vol. 502, pp. 41-54
Closed Access | Times Cited: 94
The Autism Biomarkers Consortium for Clinical Trials: evaluation of a battery of candidate eye-tracking biomarkers for use in autism clinical trials
Frederick Shic, Adam Naples, Erin Barney, et al.
Molecular Autism (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 50
Neurometabolite levels in the brains of patients with autism spectrum disorders: A meta-analysis of proton magnetic resonance spectroscopy studies (N = 1501)
Yang Du, Lei Chen, Meichen Yan, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 7, pp. 3092-3103
Closed Access | Times Cited: 33
Poly (ADP-Ribose) polymerase 1 and parthanatos in neurological diseases: From pathogenesis to therapeutic opportunities
Xiaoxue Xu, Bowen Sun, Chuansheng Zhao
Neurobiology of Disease (2023) Vol. 187, pp. 106314-106314
Open Access | Times Cited: 28
Community views of neurodiversity, models of disability and autism intervention: Mixed methods reveal shared goals and key tensions
Patrick Dwyer, Ava N. Gurba, Steven K. Kapp, et al.
Autism (2024)
Closed Access | Times Cited: 14
Leveraging AI for the Diagnosis and Treatment of Autism Spectrum Disorder: Current Trends and Future Prospects
Nitu L. Wankhede, Mayur B. Kale, Madhu Shukla, et al.
Asian Journal of Psychiatry (2024) Vol. 101, pp. 104241-104241
Closed Access | Times Cited: 11
A comparison between children and adolescents with autism spectrum disorders and healthy controls in biomedical factors, trace elements, and microbiota biomarkers: a meta-analysis
Ping Lin, Qianwen Zhang, Junyu Sun, et al.
Frontiers in Psychiatry (2024) Vol. 14
Open Access | Times Cited: 10
Biomarker Exploration in Human Peripheral Blood Mononuclear Cells for Monitoring Sulforaphane Treatment Responses in Autism Spectrum Disorder
Hua Liu, Andrew W. Zimmerman, Kanwaljit Singh, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 50
Proteomics and Metabolomics Approaches towards a Functional Insight onto AUTISM Spectrum Disorders: Phenotype Stratification and Biomarker Discovery
Maria Vittoria Ristori, Stefano Levi Mortera, Valeria Marzano, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 17, pp. 6274-6274
Open Access | Times Cited: 50
miRNAs as biomarkers of autism spectrum disorder: a systematic review and meta-analysis
Nathalia Garrido-Torres, Karem Guzmán-Torres, Susana García-Cerro, et al.
European Child & Adolescent Psychiatry (2023) Vol. 33, Iss. 9, pp. 2957-2990
Open Access | Times Cited: 20
Sulforaphane Treatment in Children with Autism: A Prospective Randomized Double-Blind Study
Martin Magner, Kateřina Thorová, Veronika Župová, et al.
Nutrients (2023) Vol. 15, Iss. 3, pp. 718-718
Open Access | Times Cited: 18
Proteomics Study of Peripheral Blood Mononuclear Cells (PBMCs) in Autistic Children
Liming Shen, Chengyun Feng, Kaoyuan Zhang, et al.
Frontiers in Cellular Neuroscience (2019) Vol. 13
Open Access | Times Cited: 51
Mitochondrial dysfunction: A hidden trigger of autism?
Balachandar Vellingiri, Kamarajan Rajagopalan, Kaavya Jayaramayya, et al.
Genes & Diseases (2020) Vol. 8, Iss. 5, pp. 629-639
Open Access | Times Cited: 45
Neurodevelopmental signatures of narcotic and neuropsychiatric risk factors in 3D human-derived forebrain organoids
Michael Notaras, Aiman Lodhi, Estíbaliz Barrio-Alonso, et al.
Molecular Psychiatry (2021) Vol. 26, Iss. 12, pp. 7760-7783
Open Access | Times Cited: 34
Dental Pulp-Derived Mesenchymal Stem Cells for Modeling Genetic Disorders
Keiji Masuda, Xu Han, Hiroki Kato, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 5, pp. 2269-2269
Open Access | Times Cited: 33
Thiol disulfide homeostasis in psychiatric disorders: A comprehensive review
Merve Ergin Tunçay, Murat İlhan Atagün, Özcan Erel
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2023) Vol. 123, pp. 110719-110719
Closed Access | Times Cited: 14
The use of data independent acquisition based proteomic analysis and machine learning to reveal potential biomarkers for autism spectrum disorder
Huajie Zhang, Xiaoxiao Tang, Chengyun Feng, et al.
Journal of Proteomics (2023) Vol. 278, pp. 104872-104872
Closed Access | Times Cited: 14
A Systematic Investigation of Complement and Coagulation-Related Protein in Autism Spectrum Disorder Using Multiple Reaction Monitoring Technology
Xueshan Cao, Xiaoxiao Tang, Chengyun Feng, et al.
Neuroscience Bulletin (2023) Vol. 39, Iss. 11, pp. 1623-1637
Closed Access | Times Cited: 13
Association of Genetic Risks With Autism Spectrum Disorder and Early Neurodevelopmental Delays Among Children Without Intellectual Disability
Nagahide Takahashi, Taeko Harada, Tomoko Nishimura, et al.
JAMA Network Open (2020) Vol. 3, Iss. 2, pp. e1921644-e1921644
Open Access | Times Cited: 35
Innovative biomarker exploration in ASD: Combining Graph Neural Networks and permutation testing on fMRI data
Donglin Wang, Wandi Ding
Neuroimage Reports (2025) Vol. 5, Iss. 2, pp. 100249-100249
Closed Access
A Combined Proteomics and Metabolomics Profiling to Investigate the Genetic Heterogeneity of Autistic Children
Liming Shen, Huajie Zhang, Lin Jing, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 6, pp. 3529-3545
Open Access | Times Cited: 18
Trace Element Changes in the Plasma of Autism Spectrum Disorder Children and the Positive Correlation Between Chromium and Vanadium
Jun Zhang, Lin Jing, Xiying Zhao, et al.
Biological Trace Element Research (2022) Vol. 200, Iss. 12, pp. 4924-4935
Closed Access | Times Cited: 16
A study of genetic heterogeneity in autism spectrum disorders based on plasma proteomic and metabolomic analysis: multiomics study of autism heterogeneity
Xiaoxiao Tang, Chengyun Feng, Yuxi Zhao, et al.
MedComm (2023) Vol. 4, Iss. 5
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top